ALX Oncology Holdings Inc. Common Stock ALXO
$2.08
+5.58%
at last close
Analyst Consensus
- Consensus Rating
- Buy (3 Buy · 0 Hold · 0 Sell)
- Average Price Target
- $4.33
- Implied Upside
- +108.3%
- Price Target Range
- $4.00 – $5.00
- Analysts (12 mo)
- 3
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-03-19 | Wells FargoDerek Archila |
Initiates coverage on | Overweight | $5 |
| 2026-03-10 | HC Wainwright & Co.Swayampakula Ramakanth |
Reiterates | Buy | $4 |
| 2026-02-05 | Piper SandlerAllison Bratzel |
Maintains | Overweight | $3 → $4 |
| 2025-05-21 | UBSColin Bristow |
Maintains | Buy | $1 → $1 |
| 2025-05-09 | HC Wainwright & Co.Swayampakula Ramakanth |
Maintains | Buy | $5 → $2 |
| 2025-03-07 | StifelBradley Canino |
Maintains | Hold | $3 → $2 |
| 2025-03-07 | HC Wainwright & Co.Swayampakula Ramakanth |
Reiterates | Buy | $5 |
| 2025-03-06 | Piper SandlerChristopher Raymond |
Maintains | Overweight | $8 → $9 |
| 2025-03-06 | JefferiesMichael Yee |
Upgrades | Hold → Buy | $2 → $3 |
| 2025-01-27 | UBSColin Bristow |
Maintains | Buy | $4 → $2 |
| 2025-01-24 | Cantor FitzgeraldLi Watsek |
Reiterates | Overweight | — |
| 2025-01-24 | HC Wainwright & Co.Swayampakula Ramakanth |
Maintains | Buy | $25 → $5 |
| 2024-12-19 | JefferiesMichael Yee |
Downgrades | Buy → Hold | $12 → $2 |
| 2024-12-18 | Cantor FitzgeraldLi Watsek |
Reiterates | Overweight | — |
| 2024-12-18 | HC Wainwright & Co.Swayampakula Ramakanth |
Reiterates | Buy | $25 |
| 2024-11-12 | Cantor FitzgeraldLi Watsek |
Reiterates | Overweight | — |
| 2024-08-16 | UBSColin Bristow |
Maintains | Buy | $25 → $4 |
| 2024-08-13 | HC Wainwright & Co.Swayampakula Ramakanth |
Reiterates | Buy | $25 |
| 2024-08-12 | Cantor FitzgeraldLi Watsek |
Reiterates | Overweight | — |
| 2024-08-09 | StifelBradley Canino |
Reiterates | Hold | $5 → $3 |
| 2024-08-01 | StifelBradley Canino |
Maintains | Hold | $14 → $5 |
| 2024-08-01 | HC Wainwright & Co.Swayampakula Ramakanth |
Reiterates | Buy | $25 |
| 2024-06-10 | HC Wainwright & Co.Swayampakula Ramakanth |
Reiterates | Buy | $25 |
| 2024-05-29 | Cantor FitzgeraldLi Watsek |
Reiterates | Overweight | — |
| 2024-04-12 | Cantor FitzgeraldLi Watsek |
Reiterates | Overweight | — |
| 2024-04-10 | HC Wainwright & Co.Swayampakula Ramakanth |
Reiterates | Buy | $20 |
| 2024-03-11 | HC Wainwright & Co.Swayampakula Ramakanth |
Maintains | Buy | $18 → $20 |
| 2024-03-08 | Piper SandlerChristopher Raymond |
Maintains | Overweight | $11 → $21 |
| 2024-03-08 | StifelBradley Canino |
Downgrades | Buy → Hold | $10 → $14 |
| 2023-12-08 | JefferiesMichael Yee |
Upgrades | Hold → Buy | $8 → $18 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $2.08
- Market Cap
- $272.41 million
- 52-Week Range
- $0.44 – $2.66
- Average Volume
- 1.01 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.